Lung Cancer Trials Ask AI to find trials
CompletedPhase 2NCT00003692
Official study title

Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer

Study summary

RATIONALE: Video-assisted surgery may be an effective treatment and have fewer side effects than conventional surgery in patients with non-small cell lung cancer. PURPOSE: Phase II trial to study the effectiveness of video-assisted surgery in treating patients who have non-small cell lung cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedtherapeutic thoracoscopy and video-assisted surgery

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 18, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 2

Interventional

Where is it offered?115 U.S. locations

Locations may change over time.

Who runs it?Alliance for Clinical Trials in Oncology

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 2
Sponsor
Alliance for Clinical Trials in Oncology
Interventions being studied
Procedure: therapeutic thoracoscopy; Procedure: video-assisted surgery
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type
Non-small cell lung cancer (NSCLC)→
Treatment approach
Surgery→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

DISEASE CHARACTERISTICS: Suspected or histologically documented non-small cell lung cancer Solitary, peripheral lung lesion that is no greater than 3.0 cm No metastatic disease No positive lymph nodes at mediastinoscopy At least 5 years since diagnosis of non-small cell or small cell lung cancer PATIENT CHARACTERISTICS: Age: Not specified Performance status: ECOG 0-2 Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Pulmonary: FEV1 at least 1.0 L or at least 50% of predicted Other: No significant comorbid medical or psychiatric condition No other active malignancy other than nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY: Not specified

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Veterans Affairs Medical Center - BirminghamBirmingham, Alabama
  • CCOP - Scottsdale Oncology ProgramScottsdale, Arizona
  • University of California San Diego Cancer CenterLa Jolla, California
  • Beckman Research Institute, City of HopeLos Angeles, California
  • Veterans Affairs Medical Center - Palo AltoPalo Alto, California
  • UCSF Cancer Center and Cancer Research InstituteSan Francisco, California
  • Veterans Affairs Medical Center - San FranciscoSan Francisco, California
  • Stanford University Medical CenterStanford, California
  • CCOP - Colorado Cancer Research Program, Inc.Denver, Colorado
  • CCOP - Christiana Care Health ServicesWilmington, Delaware
  • Lombardi Cancer Center, Georgetown UniversityWashington D.C., District of Columbia
  • Walter Reed Army Medical CenterWashington D.C., District of Columbia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 18, 2023. Always confirm current availability with the study team.

View original record ↗